Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer

Cancer

Volumn 118, Issue 17, 2012, Pages 4339-4345

  Kapadia, Nirav S ^a   Mamet, Rizvan ^b   Zornosa, Carrie ^c   Niland, Joyce C ^b   D'Amico, Thomas A ^d   Hayman, James A ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c National Comprehensive Cancer Network   (United States)

^d DUKE CANCER INSTITUTE   (United States)

Author keywords

end of life care; lung cancer; palliative care; quality indicators; radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMORBIDITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INDEPENDENT VARIABLE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT PREFERENCE; PRIORITY JOURNAL; REFERENCE DATABASE; SCORING SYSTEM; SEX DIFFERENCE; TERMINAL CARE; TREATMENT RESPONSE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT PREFERENCE; RADIOTHERAPY; TERMINAL CARE;

EID: 84865328647     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27401     Document Type: Article

References (23)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. National Center for Health Statistics. SEER 9 Areas and US Mortality Files 2007. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control and Prevention; 2007. Available from: http://seer.cancer.gov/ csr/1975-2007/. Accessed November 1, 2010.
3. Hayman JA, Abrahamse PH, Lakhani I, Earle CC, Katz SJ,. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007; 69: 1001-1007.
4. Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005; 17: 505-509.
5. Barbera L, Paszat L, Chartier C,. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care. 2006; 22: 12-17.
6. Horner MJ, Riesl AG, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2006 [based on the November 2008 SEER data submission, posted to the SEER web site 2009]. Bethesda, MD: National Cancer Institute; 2009. Available from: http://seer.cancer.gov/csr/1975-2006/. Accessed November 1, 2010.
7. Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Solomans J, Mackillop WJ,. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001; 19: 137-144.
8. Lavergne MR, Johnston G, Gao J, Dummer TJB, Rheaume DE,. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med. 2010; 25: 101-110.
9. Hogan C,. Medicare beneficiaries' costs of care in the last year of life. Health Aff (Millwood). 2001; 20: 188-195.
10. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363: 733-742.
11. Johnston GM, Boyd CJ, Joseph P, MacIntyre M,. Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol. 2001; 19: 3323-3332.
12. Lutz S, Spence C, Chow E, Janjan N, Connor S,. Survey on the use of palliative radiotherapy in hospice care. J Clin Oncol. 2004; 22: 3581-3586.
13. Gadgeel SM, Ramalingam S, Cummings G, et al. Lung cancer in patients â‰50 years of age: the experience of an academic multidisciplinary program. Chest. 1999; 115: 1232-1236.
14. Magne N, Chargari C, Mirimanoff RO, et al. European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey. Support Care Cancer. 2011; 19: 1565-1572.
15. Fairchild A, Barnes E, Ghosh S, et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys. 2009; 75: 1501-1510.
16. Konski A,. Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14. Int J Radiat Oncol Biol Phys. 2006; 66: 229-233.
17. Rades D, Stalpers LJ, Hulshof MC, Zschenker O, Alberti W, Koning CC,. Effectiveness and toxicity of single-fraction radiotherapy with 1Ã - 8 Gy for metastatic spinal cord compression. Radiother Oncol. 2005; 75: 70-73.
18. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003; 327: 195-198.
19. Forster LE, Lynn J,. Predicting life span for applicants to inpatient hospice. Arch Intern Med. 1988; 148: 2540-2543.
20. Christakis N, Lamont EB,. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000; 320: 469-472.
21. Mackillop WJ, Quirt CF,. Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol. 1997; 50: 21-29.
22. Gripp S, Mjartan S, Boelke E, Willers R,. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer. 2010; 116: 3251-3256.
23. Erikson C,. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007; 3: 79-86.